# A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

> **NCT00619164** · PHASE2 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** E5555
- **DRUG:** E5555
- **DRUG:** E5555
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00619164
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-09
- **Final completion:** —
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619164, "A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00619164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*